Wei-li Ma
TPQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Increased CCR5 expression in lymphoma cells and M2 macrophages is associated with poor prognosis in primary intestinal diffuse large B-cell lymphoma.
Journal: The journal of pathology. Clinical research
Published: April 11, 2026
Prospective phase II study of frontline Helicobacter pylori eradication therapy for early-stage extragastric mucosa-associated lymphoid tissue lymphoma.
Journal: Blood cancer journal
Published: December 09, 2025
Rituximab, Acalabrutinib, and Durvalumab for Primary Central Nervous System Lymphoma: A Single-Arm, Phase Ib, Multicenter Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 09, 2025
Acquired MYC rearrangement potentially associated with ibrutinib resistance in mantle cell lymphoma.
Acquired MYC rearrangement potentially associated with ibrutinib resistance in mantle cell lymphoma.
Journal: Virchows Archiv : an international journal of pathology
Published: June 11, 2025
Hematopoietic cell transplantation for blood cancer patients living with HIV in Taiwan - A case series.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: October 04, 2024
Hormone therapy enhances anti-PD1 efficacy in premenopausal estrogen receptor-positive and HER2-negative advanced breast cancer.
Journal: Cell reports. Medicine
Published: May 24, 2024
Complete response to front-line therapies is associated with long-term survival in HIV-related lymphomas in Taiwan.
Journal: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
Published: December 20, 2023
Delay of Surgery for Spinal Metastasis due to the COVID-19 Outbreak Affected Patient Outcomes.
Journal: Neurospine
Published: July 03, 2023
Improved outcomes of localized diffuse large B-cell lymphoma at the Waldeyer ring in comparison to the sinonasal area in the rituximab era.
Journal: Cancer medicine
Published: March 27, 2023
Long-term outcomes of combined intravitreal methotrexate and systemic high-dose methotrexate therapy in vitreoretinal lymphoma.
Journal: Cancer medicine
Published: October 07, 2022
Last Updated: 09/26/2026